EPISODE · Dec 13, 2024 · 1 MIN
Mark Cuban's surprising take on Elon Musk and the online pharmacy industry
from GREY Journal Daily News Podcast
Mark Cuban launched the Mark Cuban Cost Plus Drug Company to provide affordable medications by selling them at a fixed mark-up over cost. The company, co-founded with Alex Oshmyansky, prioritizes transparency in the pharmaceutical sector and aims to challenge high drug prices. It operates with the goal of improving healthcare access rather than maximizing profits. The initiative addresses rising medication costs and promotes sustainable, ethical practices within the healthcare system. The company plans to offer a wide range of medications and leverages technology and an innovative supply chain model to maintain low prices. Its growth highlights ongoing discussions about healthcare costs and corporate responsibility in the industry. Learn more on this news visit us at: https://greyjournal.net/ Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
Mark Cuban launched the Mark Cuban Cost Plus Drug Company to provide affordable medications by selling them at a fixed mark-up over cost. The company, co-founded with Alex Oshmyansky, prioritizes transparency in the pharmaceutical sector and aims to challenge high drug prices. It operates with the goal of improving healthcare access rather than maximizing profits. The initiative addresses rising medication costs and promotes sustainable, ethical practices within the healthcare system. The company plans to offer a wide range of medications and leverages technology and an innovative supply chain model to maintain low prices. Its growth highlights ongoing discussions about healthcare costs and corporate responsibility in the industry. Learn more on this news visit us at: https://greyjournal.net/ Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Mark Cuban's surprising take on Elon Musk and the online pharmacy industry
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m